Adiponectin protects against paraquat-induced lung injury by attenuating oxidative/nitrative stress. by Yao, Rong et al.
Thomas Jefferson University
Jefferson Digital Commons
Department of Emergency Medicine Faculty Papers Department of Emergency Medicine
1-1-2015
Adiponectin protects against paraquat-induced
lung injury by attenuating oxidative/nitrative stress.
Rong Yao
West China Hospital
Yaxiong Zhou
West China Hospital
Yarong He
West China Hospital
Yaowen Jiang
West China Hospital
Peng Liu
West China Hospital
See next page for additional authors
Let us know how access to this document benefits you
Follow this and additional works at: https://jdc.jefferson.edu/emfp
Part of the Emergency Medicine Commons
This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital Commons is a service of Thomas
Jefferson University's Center for Teaching and Learning (CTL). The Commons is a showcase for Jefferson books and journals, peer-reviewed scholarly
publications, unique historical collections from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and
interested readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been accepted for inclusion in
Department of Emergency Medicine Faculty Papers by an authorized administrator of the Jefferson Digital Commons. For more information, please
contact: JeffersonDigitalCommons@jefferson.edu.
Recommended Citation
Yao, Rong; Zhou, Yaxiong; He, Yarong; Jiang, Yaowen; Liu, Peng; Ye, Lei; Zheng, Zhijie; Lau, Wayne
Bond; Cao, Yu; and Zeng, Zhi, "Adiponectin protects against paraquat-induced lung injury by
attenuating oxidative/nitrative stress." (2015). Department of Emergency Medicine Faculty Papers.
Paper 47.
https://jdc.jefferson.edu/emfp/47
Authors
Rong Yao, Yaxiong Zhou, Yarong He, Yaowen Jiang, Peng Liu, Lei Ye, Zhijie Zheng, Wayne Bond Lau, Yu Cao,
and Zhi Zeng
This article is available at Jefferson Digital Commons: https://jdc.jefferson.edu/emfp/47
EXPERIMENTAL AND THERAPEUTIC MEDICINE  9:  131-136,  2015
Abstract. The specific mechanisms underlying paraquat 
(PQ)-induced lung injury remain unknown, which limits 
understanding of its cytotoxic potential. Although oxida-
tive stress has been established as an important mechanism 
underlying PQ toxicity, multiple antioxidants have proven 
ineffective in attenuating the deleterious effects of PQ. 
Adiponectin, which shows anti-oxidative and antinitra-
tive effects, may have the potential to reduce PQ-mediated 
injury. The present study determined the protective action 
of globular domain adiponectin (gAd) on PQ-induced lung 
injury, and attempted to elucidate the underlying mechanism 
or mechanisms of action. BALB/c mice were administered 
PQ, with and without 12 or 36 h of gAd pre-treatment. 
The pulmonary oxidative/nitrative status was assessed 
by measuring pulmonary O2•‑, superoxide dismutase 
(SOD), malondialdehyde (MDA), nitric oxide (NO) and 
8-hydroxy-2-dydeoxy guanosine (8-OHdG) production, 
and blood 3-Nitrotyrosine (3-NT). At a dose of 20 mg/kg, 
PQ markedly increased O2•‑, SOD, MDA, NO and 8-OHdG 
production 3 h post‑administration, but did not significantly 
increase 3-NT levels until 12 h. gAd inhibited these changes 
in a dose-dependent manner, via transient activation of MDA, 
followed by attenuation of MDA formation from 6 h onwards. 
Histological analysis demonstrated that gAd decreased inter-
stitial edema and inflammatory cell infiltration. These results 
suggest that gAd protects against PQ-induced lung injury by 
mitigating oxidative/nitrative stress. Furthermore, gAd may 
be a potential therapeutic agent for PQ-induced lung injury, 
and further pharmacological studies are therefore warranted.
Introduction
Paraquat (1,1'-dimethyl-4,4'-bipyridinium dichloride; PQ) is 
a widely-utilized non-selective herbicide for the control of 
broadleaf weed. Available therapies for PQ poisoning lack 
efficacy, and it is a major cause of herbicide‑related mortality, 
which occurs due to respiratory failure secondary to lung 
injury (1). Although the specific mechanisms of PQ toxicity 
have not been fully defined, it is hypothesized that PQ toxicity 
involves the generation of reactive oxygen species (ROS), 
leading to subsequent oxidative stress, which results in cell 
death and lung tissue damage (1,2). Antioxidants that directly 
inhibit ROS generation have been proposed as possible thera-
peutic agents in PQ-induced lung injury. However, traditional 
antioxidants, such as glutathion and vitamin C, have failed to 
protect against the characteristic pathological lung changes 
or mortality observed in PQ poisoning (1). Therefore, mecha-
nisms other than oxidative stress may also be responsible 
for the pulmonary toxicity of PQ. The identification of such 
mechanisms may yield insight into the development of novel 
therapeutic agents and is an important area of research.
Adiponectin (also termed Acrp30, AdipoQ and GBP28) 
is a protein predominantly secreted from adipose tissue (3-5). 
Primary sequence analysis has revealed that full-length 
adiponectin has four main domains, with the globular segment 
(gAd) at the carboxy terminus being much more potent than 
the full protein (6,7). Adiponectin has been demonstrated to 
exhibit anti‑oxidative and anti‑inflammatory effects (8). The 
mechanisms of its actions are varied and depend upon the site 
of activity. In endothelial cells, adiponectin enhances nitric 
oxide (NO) production, suppresses the production of ROS and 
protects against inflammation mediated by hyperglycemic 
states or tumor necrosis factor, via activation of AMP-activated 
protein kinase and cyclic AMP-dependent protein kinase 
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signaling cascades (9). It was hypothesized that globular 
domain adiponectin (gAd) may protect against PQ-induced 
lung injury by attenuating oxidative/nitrative stress.
The present study aimed to determine whether gAd protects 
against PQ-induced pulmonary injury in BALB/c mice and 
to determine the underlying mechanism or mechanisms of 
action. Ultimately the aim would be to assess the potential of 
adiponectin as a novel therapeutic agent in PQ-induced lung 
injury.
Materials and methods
Materials. PQ was obtained from Tokyo Kasei Kogyo Co., 
Ltd. (Tokyo, Japan). Recombinant mouse gAd was obtained 
from Adipobiotech Inc. (Beijing, China). Enzyme-linked 
immunosorbent assay (ELISA) kits for 3-Nitrotyrosine 
(3-NT) were obtained from Abcam (Cambridge, MA, USA). 
8-hydroxy-2-dydeoxy guanosine (8-OHdG) EIA and super-
oxide dismutase (SOD) assay kits were obtained from Cayman 
Chemical Co. (Ann Arbor, MI, USA). Dihydroethidium (DHE) 
probes were obtained from Merck Millipore (Darmstadt, 
Germany). Malondialdehyde (MDA) EIA kits were obtained 
from BioVision, Inc, (Milpitas CA, USA). The NO ELISA kit 
was obtained from 4A Biotech Co., Ltd. (Beijing, China).
Animals and treatment. Male BALB/c mice were obtained 
from Dossy Biological Technology Co., Ltd. (Chengdu, China). 
They were housed at 22±2˚C in a humidity‑controlled room 
with free access to fresh water and standard laboratory food. 
Following 1 week of conditioning in a 12 h light/dark cycle, 
eighty male mice were randomly divided into four groups: (i) 
Control group (saline injection); (ii) PQ + low-gAd group (PQ 
exposure combined with gAd pre-treatment at 500 µg/kg by 
tail vein injection at 12 and 36 h prior to PQ administration); 
(iii) PQ + high-gAd group (PQ exposure combined with gAd 
pre-treatment at 1000 µg/kg by tail vein injection at 12 and 
36 h prior to PQ administration); and (iv) PQ (20 mg/kg) 
group, intraperitoneal administration (IP). The dose for 
high/low gAd was determined from preliminary experiments 
(data not shown). Mice were anesthetized with 50 mg/kg 
pentobarbital (Hanlim Pharm. Co. Ltd., Seoul, Korea), IP. 
Serum and pulmonary samples were collected at 3, 6, 12, 
24 and 72 h post-PQ injection. The study was conducted in 
accordance with the ethical standards in the 1986 Directive 
86/609/EEC, European Convention for the Protection 
of Vertebrate Animals Used for Experimental and other 
Scientific Purposes, and the Guiding Principles in the Use of 
Animals in Toxicology, adopted by the Society of Toxicology 
in 1989. The study was approved by the Committee on the 
Ethics of Animal Experiments of the Sichuan University 
(permit no. 26).
Histopathological assessment of pulmonary tissue. 
Pulmonary tissue, fixed in 10% neutral‑buffered formalin, 
was blocked in paraffin using an automated processor (Leica, 
Nussloch，Germany), with graded alcohol, xylene and 
paraffin. Sections (4 µm) were stained using hematoxylin and 
eosin. Digital images of the stained glass slides were obtained 
using a ScanScope Digital slide scanner (Aperio Technologies, 
Inc., Vista, CA, USA) at a magnification of x100.
Measurement of superoxide anion in pulmonary tissue. 
Lung segments obtained from control and PQ-treated mice 
were embedded in tissue freezing medium (Tris-buffered 
saline; Thermo Fisher Scientific, Waltham, MA, USA). 
Following freezing, 30-µm segments were cut, and mounted 
and cover-slipped on glass slides. Sections were treated with 
2 µmol/l DHE in dimethyl sulfoxide buffer. Slides were 
incubated in a light‑protected chamber at 37˚C for 30 min. 
Ethidium-stained tissue was observed by inverted fluores-
cent microscopy at a magnification of x100 (Olympus IX71, 
Olympus, Tokyo, Japan) following excitation (485 nm) and 
emission (535 nm). Control and PQ-treated pulmonary samples 
were processed and imaged in parallel.
Measurement of pulmonary tissue MDA, SOD, NO and 
8‑OHdG levels, and blood 3‑NT levels. Pulmonary tissue 
levels of MDA, SOD, NO and 8-OHdG, and blood levels of 
3-NT from control and PQ-treated mice were determined 
using ELISA kits, according to the manufacturer's instructions.
Statistical analysis. All values are expressed as the 
mean ± standard deviation. Comparisons between groups at 
each time point were made by one-way analysis of variance, 
followed by Student-Newman-Keul's test. P<0.05 was consid-
ered to indicate a statistically significant difference.
Results
gAd attenuated PQ‑mediated pulmonary interstitial edema 
and inflammatory cell infiltration in a dose‑dependent 
manner. Compared with the control group (Fig. 1A), PQ 
administration caused acute injury to pulmonary tissue, as 
demonstrated by the interstitial edema and inflammatory cell 
infiltration (lymphocytes and histiocytes) observed in the 
alveolar space and septum (Fig. 1B). Pre-treatment with gAd 
inhibited these changes (Fig. 1C and D) in a dose-dependent 
manner.
gAd reduced PQ‑induced pulmonary oxidative injury in 
a dose‑dependent manner. Three series of experiments 
were performed to determine the effects of PQ and gAd on 
oxidative stress in the mouse lung. In the first series, in situ O2•‑ 
generation was detected by DHE staining. Weak DHE staining 
was observed in the pulmonary tissue of control animals, 
indicating the basal pulmonic O2•‑ production (Fig. 2A). The 
staining was significantly intensified in mice subjected to PQ 
administration (Fig. 2B). By contrast, gAd (at high and low 
doses, Fig. 2C and D) decreased this augmented staining.
In the second series of experiments, pulmonary tissue MDA 
content was found to be significantly increased in mice subjected 
to PQ administration at as early as 3 h following initial PQ 
exposure (Fig. 3). This increase was eliminated from 6 to 72 h 
following the initial PQ exposure, by pre-treatment with gAd.
In the third series of experiments, pulmonary SOD levels 
were found to be significantly increased at all time points 
measured in animals subjected to PQ administration compared 
with the control group (Fig. 4). Notably, the augmented SOD 
activity was further amplified by pre‑administration of gAd at 
3 h, although it was decreased from 6 to 72 h, in accordance 
with the trend in MDA levels.
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gAd reduced PQ‑induced pulmonary nitrative injury in a 
dose‑dependent manner. NO production was significantly 
increased in PQ-exposed mice compared with the control 
group. This augmentation was significantly reduced in 
gAd-pre-treated mice compared with the PQ group (Fig. 5). 
As a consequence of the induced NO production, blood 3-NT 
levels were also increased in the PQ-exposed mice compared 
with the control group. gAd administration decreased the 
blood 3-NT level, particularly from 24 to 72 h following 
PQ-exposure (Fig. 6).
Figure 1. Effect of gAd pre‑treatment on pulmonary edema and inflammatory 
cell infiltration in control animals or PQ‑exposed animals, treated with vehicle 
or gAd (high-dose or low-dose) 24 h prior to PQ injection. (A) Control group; 
(B) PQ (20 mg/kg) group; (C) high-dose gAd (1000 µg/kg); and (D) low-dose 
gAd (500 µg/kg). Values represent the mean ± standard error of the mean of 
four parallel measurements. gAd, globular domain adiponectin; PQ, paraquat. 
Stain, hematoxylin and eosin; magnification, x100.
Figure 2. Effect of gAd pre-treatment on pulmonary superoxide anions in the 
lungs from control animals or PQ-exposed animals, treated with vehicle or 
gAd (high-dose or low-dose) 24 h prior to PQ injection. (A) Control group; 
(B) PQ (20 mg/kg) group; (C) high-gAd (1000 µg/kg); and (D) low-gAd 
(500 µg/kg). Values represent the mean ± standard error of the mean of four 
parallel measurements. gAd, globular domain adiponectin; PQ, paraquat. 
Stain, dihydroethidium; magnification, x100.
Figure 3. Effect of gAd pretreatment on pulmonary MDA level in control 
animals or PQ-exposed animals, treated with vehicle or gAd (high-dose or 
low-dose) at 0, 3, 6, 12, 24 and 72 h after PQ injection. MDA levels were 
determined by an enzyme-linked immunosorbent assay. Values represent the 
mean ± standard error of the mean of four parallel measurements. *P<0.05, 
compared with controls and #P<0.05, compared with the PQ group. gAd, 
globular domain adiponectin; MDA, malondialdehyde; PQ, paraquat.
Figure 4. Effect of gAd pre-treatment on pulmonary SOD level in control 
animals or PQ-exposed animals, treated with vehicle or gAd (high-dose or 
low-dose) at 0, 3, 6, 12, 24 and 72 h following PQ injection. SOD levels were 
determined by an enzyme-linked immunosorbent assay. Values represent the 
mean ± standard error of the mean of four parallel measurements. *P<0.05, 
compared with controls and #P<0.05, compared with the PQ group. gAd, 
globular domain adiponectin; SOD, superoxide dismutase; PQ, paraquat.
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Similarly, a marked increase in pulmonary 8-OHdG levels 
was observed in PQ-exposed mice compared with the control 
group. The increase was decreased by gAd pre-treatment to 
a degree at all time points measured, and this reduction was 
significant compared with the PQ group at 72 h (Fig. 7).
Discussion
Previous experimental and clinical studies have demonstrated 
that PQ directly contributes to lung injury by inducing inflam-
mation, edema and fibrosis (10‑13). In the present study, gAd 
pre-treatment mitigated the pathological changes induced 
by PQ in a dose-dependent manner. This provides evidence 
that the adipocytokine, adiponectin, which is known to have 
antidiabetic (14), anti-atherogenic (15), antitumor (16) and 
anti‑inflammatory properties (17,18), also exerts a pulmonary 
protective effect against PQ-induced injury.
The current study indicated that the possible mechanisms 
by which gAd relieves PQ-induced lung injury may be attrib-
uted to two effects. gAd protects mice against PQ-induced 
lung injury by attenuating oxidative stress. In addition, gAd 
protects against PQ-induced lung injury by mitigating nitra-
tive stress.
PQ is a toxic herbicide that particularly affects the lungs, 
since the pulmonary polyamine uptake system preferentially 
recruits PQ, resulting in a 6-10 fold increase in lung levels 
compared with the plasma (19,20). PQ is known to induce 
alveolar collapse and fibrosis (21). Such effects are due to 
the imbalance between the formation and scavenging of 
ROS (1,2,22). ROS overproduction damages cell membranes, 
resulting in lipid peroxidation, for which MDA levels serve as 
a proxy measurement (23). SOD is a mammalian enzymatic 
defense system, which protects against oxidative injury by 
scavenging excess O2-. It also indirectly reflects the level of 
lipid peroxidation (24). The present study demonstrated that 
PQ significantly increases MDA production and activates 
SOD, which was consistent with a previous study (25) This 
suggests that PQ simultaneously stimulates oxidative stress 
injury and anti-oxidative defenses to ameliorate lipid peroxi-
dation.
Consistent with previous reports, adiponectin potently 
scavenges free radicals, leading to the inhibition of lipid 
peroxidation (6). In the current study, it was demonstrated 
that gAd administration 12 and 36 h prior to PQ exposure 
significantly attenuated O2
- generation and MDA production. 
To the best of our knowledge, this study provides the first 
direct evidence supporting the hypothesis that adiponectin 
modulates antioxidant defense mechanisms in the lung, and 
Figure 5. Effect of gAd pretreatment on pulmonary NO level in control 
animals or PQ-exposed animals, treated with vehicle or gAd (high-dose or 
low-dose) at 0, 3, 6, 12, 24 and 72 h following PQ injection. NO levels were 
determined by an enzyme-linked immunosorbent assay. Values represent the 
mean ± standard error of the mean of four parallel measurements. *P<0.05, 
compared with controls and #P<0.05, compared with the PQ group. gAd, 
globular domain adiponectin; NO, nitric oxide; PQ, paraquat.
Figure 6. Effects of gAd pretreatment on blood 3-NT level in control animals 
or PQ-exposed animals, determined by an enzyme-linked immunosorbent 
assay at 0, 3, 6, 12, 24 and 72 h. Values represent the mean ± standard error 
of the mean of four parallel measurements. *P<0.05, compared with controls 
and #P<0.05, compared with the PQ group. gAd, globular domain adipo-
nectin; 3-NT, 3-nitrotyrosine; PQ, paraquat.
Figure 7. Effects of gAd pretreatment on pulmonary 8-OdGH in control 
animals or PQ-exposed animals, determined by an enzyme-linked immuno-
sorbent assay at 0, 3, 6, 12, 24 and 72 h. Values represent the mean ± standard 
error of the mean of four parallel measurements. *P<0.05, compared with 
controls and #P<0.05, compared with the PQ group. gAd, globular domain 
adiponectin; 8-OdGH, 8-hydroxy-2-dydeoxy guanosine; PQ, paraquat.
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could thus offer protection against PQ-induced lung damage 
via attenuation of oxidative and nitrative stresses.
Contrary to findings from previous studies (26,27), gAd 
pre-treatment at high or low doses only augmented SOD 
activities at 3 h following initial PQ exposure. By contrast, 
SOD activity was lower in the gAd groups compared with the 
PQ group following 6 to 72 h. There are a number of possible 
explanations for this effect. The most plausible of these is that 
gAd may stimulate anti-oxidative SOD activity in a burst-like 
manner, which would diminish ROS and MDA levels such 
that the higher levels of SOD producing the anti-oxidant effect 
were no longer required. An alternative explanation is that the 
short half-life (~13-17.5 h) of gAd in circulation (28) may limit 
its anti-oxidative properties over a prolonged period.
Other than ROS, reactive nitrogen species (RNS), including 
NO and ONOO-, mediate nitrative stress via the nitration of 
various biomolecules, including proteins, lipids and nucleic 
acids (29). Accumulating evidence has demonstrated that PQ 
augments NO and ONOO- production, suggesting that RNS 
are also involved in PQ-mediated pulmonary injury (30-33). 
The current study showed that PQ significantly increased 
NO production, which emphasized the pathophysiological 
importance of NO in PQ-mediated lung injury. In contrast 
to its effects in an endothelial model (34), pre-treatment with 
gAd significantly reduced NO production in PQ‑exposed mice 
lung. A possible explanation may be that gAd causes different 
effects in different cells or tissues under different stimulation.
Excess NO reacts with O2- to produce ONOO- (35,36). 
ONOO- is a highly toxic reactive species, which nitratively 
modifies various proteins, for example, changing tyrosine to 
3-NT (37). ONOO- also injures DNA via a number of mecha-
nisms, including the formation of 8-OHdG (38). The present 
study demonstrated an increase in 8-OHdG levels in lung 
tissue from 6 to 72 h, and increased 3-NT from 12 to 72 h, in 
PQ-exposed mice. These results provide additional evidence 
in support of the hypothesis that nitrative stress is involved in 
PQ-mediated injury (39). gAd pre-treatment markedly attenu-
ated 3-NT production at 24 and 72 h, and decreased 8-OHdG 
after 72 h. To the best of our knowledge, this is the first evidence 
demonstrating that adiponectin protects against PQ-mediated 
lung injury by attenuating peroxynitrite-induced protein nitra-
tion and DNA damage via a reduction in nitrative stress.
In conclusion, the present study demonstrates that gAd 
protects against PQ-induced lung injury in a BALB/c 
mouse model, by attenuating oxidative/nitrative stress in a 
dose-dependent manner. Adiponectin is therefore a potential 
therapeutic agent against PQ-induced lung injury, for which 
no efficacious treatment currently exists. Clarification of the 
precise signaling mechanisms involved in the amelioration 
of oxidative/nitrative stress by adiponectin requires further 
investigation. In addition, further studies are required in order 
to assess the effect of gAD given with and following PQ 
administration, as the current study, which only examined the 
effect of pre-treatment with gAd, does not accurately mimic 
true clinical scenarios.
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